Cost Guide · 2026
Tirzepatide Cost with Cash Pay: 2026 Pricing
Tirzepatide is FDA-approved and and its cost through cash pay depends on several factors. This guide covers everything you need to know about Tirzepatide pricing in 2026.
⚠️ Medical Disclaimer
This page is for educational purposes only and does not constitute medical advice. GLP-1 medications are prescription drugs. Discuss all treatment decisions with a licensed healthcare provider who knows your complete medical history. Individual results vary significantly from clinical trial averages.
List Price
$1086/month
With Insurance
$50/month (with approved coverage)
Prior Auth
Yes — required by most plans
Tirzepatide + Cash Pay: What to Expect
Cash-pay patients typically pay list price or slightly below via manufacturer discount programs. Manufacturer savings cards (Eli Lilly's Zepbound Savings Card, Novo Nordisk's NovoCare program) can significantly reduce costs for eligible patients without government insurance.
Price Breakdown by Coverage Type
| Coverage Type | Typical Monthly Cost | Notes |
|---|---|---|
| List price (cash) | $1086/month | Without any coverage or discount |
| Commercial insurance | $50/month (with approved coverage) | Highly variable by plan and formulary tier |
| Manufacturer savings card | As low as $25–$50/month (commercially insured) | Eligibility restrictions apply; not for Medicare/Medicaid patients |
| Compounded | $399/month | Availability depends on FDA shortage status |
Prior Authorization Requirements
Prior authorization (PA) is required by most commercial insurers and Medicare Part D plans. The PA process typically requires:
- Diagnosis of obesity (BMI ≥30) or overweight (BMI ≥27) with at least one weight-related comorbidity
- Documentation of previous lifestyle modification attempts
- Sometimes: failure of prior obesity pharmacotherapy (step therapy)
- Sometimes: specific HbA1c criteria for diabetic indications
Prior authorization approval rates vary significantly by payer. Your prescriber's office can assist with the PA process.
Manufacturer Savings Programs
Savings card eligibility: Commercially insured patients (not Medicare/Medicaid) may qualify for significant savings through manufacturer programs. Contact the manufacturer directly for current program details and income eligibility thresholds.
Cost-Reduction Strategies
- GoodRx: Compare pharmacy prices — variation of $50–$150/month between pharmacies is common
- 90-day supply: Many pharmacies and mail-order programs offer 10–20% savings on 90-day fills
- Patient assistance programs: Income-based programs may provide the medication at low or no cost for qualifying patients
- Compounded alternatives: When brand is on FDA shortage, licensed 503B compounding pharmacies may offer significantly lower prices
- HSA/FSA funds: Pre-tax dollars can be used for prescription costs — effectively reducing cost by your marginal tax rate
- Clinical trials: Eligible patients may receive medication at no cost through clinical trial participation — see ClinicalTrials.gov
Tirzepatide 2026 Cost Outlook
GLP-1 medication pricing continues to evolve. Key factors affecting Tirzepatide costs in 2026 include: increased formulary competition from newer agents (tirzepatide, pending approvals), potential Medicare negotiation under the Inflation Reduction Act, and the ongoing consolidation of the compounding pharmacy landscape following FDA shortage delisting.
💰 Cost Estimator Calculator
Enter your specific insurance details to get a personalized cost estimate for Tirzepatide and alternatives.
Open Cost Estimator →